Trump DOJ Forces Cleveland Clinic Into 20-Year Ban on Gender-Affirming Care for Minors
The Trump Justice Department has secured a sweeping settlement with the Cleveland Clinic that bans the hospital system from providing gender-affirming medical care to patients under 18 for the next two decades — the latest and most aggressive move in the administration’s campaign to eliminate transgender healthcare for minors across the country.
The agreement, announced Monday, prohibits the Cleveland Clinic from administering puberty blockers, cross-sex hormones, or any other gender-transition interventions to minors for 20 years, regardless of future changes to Ohio state law.
The settlement also requires the Cleveland Clinic to contribute $2 million toward care for detransitioners and pay $308,000 to resolve allegations of Medicaid billing irregularities tied to treatments provided to minors.
A Settlement Built on Contested Legal Ground
The Justice Department framed the agreement as protecting children from “irreversible medical interventions,” language used by Associate Attorney General Stanley Woodward in Monday’s announcement. But the framing is medically and legally contested.
Major medical organizations — including the American Academy of Pediatrics, the American Medical Association, and the Endocrine Society — support access to gender-affirming care for minors as evidence-based treatment for gender dysphoria, with appropriate clinical oversight and informed consent processes involving patients and their families.
The Cleveland Clinic said the billing issue arose from what it described as an unintentional coding error affecting a limited number of patients, and said it cooperated with investigators to resolve the matter. The hospital did not publicly contest the broader treatment ban.
Ohio Already Had Restrictions — The DOJ Went Further
The settlement is notable in part because Ohio already bans gender-transition treatments for minors under state law. The federal agreement goes further by locking in the prohibition for 20 years, insulating it from any future legislative or judicial reversal at the state level.
That structure — using a civil settlement to entrench policy beyond the reach of future democratic processes — raises significant questions about the administration’s use of federal legal power to impose ideological priorities on healthcare institutions.
Part of a Broader Federal Campaign
The Cleveland Clinic deal follows a similar settlement last month with Texas Children’s Hospital, which the Justice Department said included financial penalties and the creation of services for detransitioning patients.
Together, the agreements signal that the Trump administration is systematically using DOJ investigations and Medicaid enforcement as leverage to pressure major hospital systems into abandoning gender-affirming care programs — even in cases where the underlying medical billing allegations are narrow or uncontested.
The administration has made investigations of pediatric gender-transition care a stated enforcement priority, arguing that minors cannot meaningfully consent to treatments with long-term effects. Clinicians and patient advocates counter that the same logic, applied consistently, would eliminate a wide range of pediatric medical interventions — and that denying care carries its own serious, documented risks, including elevated rates of depression and suicide among transgender youth.
What the Settlement Means
The Cleveland Clinic is one of the most prominent hospital systems in the United States, routinely ranked among the top medical centers in the country. The reach and duration of this settlement make it one of the most consequential actions yet in the administration’s effort to reshape the landscape of transgender healthcare through federal enforcement power.